RxDoctor Payments Data

Dharmaraj Patil

Internal Medicine · Alpharetta, GANPI 1558355685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 26.3% of the total. Reporting peaked in 2020 at $619 and has fallen 91.0% since, to $56 in 2022.

$1,720in general payments, 2019–2025

Across 105 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$452
  • Novo Nordisk$380
  • Lilly USA, LLC$176
  • Boehringer Ingelheim$102
  • AbbVie$95
  • Arbor Pharmaceuticals, Inc.$61
  • plus $452 from 13 others

What the payments were for

  • Food & beverage$1,720100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,720 in reported general payments places this provider in the 75th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Other internal medicine in Alpharetta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →